|
MechanismEpCAM inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with DLRC Pharma Services
0 Patents (Medical) associated with DLRC Pharma Services
100 Deals associated with DLRC Pharma Services
100 Translational Medicine associated with DLRC Pharma Services